JSC Olainfarm informs that in 2020 disclosure of financial results is scheduled for the following dates:

  • Unaudited consolidated interim financial statements for 12 months - on 28 February 2020;
  • Unaudited consolidated interim financial statements for 3 months - on 29 May 2020;
  • Unaudited consolidated interim financial statements for 6 months - on 31 August 2020;
  • Unaudited consolidated interim financial statements for 9 months – on 30 November 2020.

Audited consolidated and unconsolidated Annual Report of JSC Olainfarm for 2019 submission planned on 30 April 2020.

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top -quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 60 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Additional information:  
Jānis Dubrovskis
Investor Relations Advisor of JSC Olainfarm
Phone: +371 29178878
Email: janis.dubrovskis@olainfarm.com